Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.32 USD
Change Today 0.00 / 0.00%
Volume 41.8K
DRIO On Other Exchanges
As of 8:10 PM 10/5/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

9 Halamish Street

Caesarea Industrial Park

Caesarea, 38900


Phone: 972 4 770 4054


LabStyle Innovations Corp. operates as a mobile health (mHealth) company. The company develops and commercializes a patented and proprietary technology providing consumers with laboratory-testing capabilities using smart phones and other mobile devices. The company’s principal operating subsidiary, Labstyle Innovation Ltd., is an Israeli company. Dario The company’s product, Dario, is a mobile, cloud-based, diabetes management solution which includes novel software applications combined with a ‘all-in-one’, pocket-sized, blood glucose monitoring device, which the company calls the Dario Smart Meter. The company is applying its technology to address the estimated worldwide market for diabetic self-monitoring of blood glucose (known as SMBG) market. Dario is a comprehensive system incorporating patented and proprietary technology that combines a software application (commonly known as an app) and cloud-based data services with a novel, all-in-one SMBG device (the Dario Smart Meter) consisting of a lancet (to obtain a blood sample), a device-specific disposable test strip cartridge and a smart mobile device-driven glucose reader adaptor. Sales and Marketing The company’s sales and marketing activities focus on the early adopter diabetics. The company plans to initially focus on insulin dependent diabetic patients. With its initial market launch, the company addresses the European market, as well as Australia and New Zealand. In 2015, the company entered into an agreement with Israel's healthcare HMO; Maccabi Healthcare, to implement a comprehensive Dario digital suite for patients and professionals. Target Markets The principal markets that the company targets for Dario include the European Union, the United States, Australia and New Zealand. History LabStyle Innovations Corp. was founded in 2011. The company was incorporated in Delaware 2011.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DRIO:US $0.32 USD 0.00

DRIO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for DRIO.
View Industry Companies

Industry Analysis


Industry Average

Valuation DRIO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 33.0x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 28.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LABSTYLE INNOVATIONS CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at